Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Prognostic significance of pulmonary involvement in idiopathic multicentric castleman disease

Yu-han Gao, Jia-min Zhou, Cong-Wei Jia, Siyuan Li, Yue Dang, Lu Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 1229.

https://doi.org/10.1182/blood-2025-1229

Published: 2025

Journal Articles

Is 'severe’ imcd-IPL really severe?

Siyuan Li, Yu-han Gao, Yue Dang, Jian Li, Lu Zhang

Blood (2025) 146 (Supplement 1): 1816.

https://doi.org/10.1182/blood-2025-1816

Published: 2025

Journal Articles

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5601.

https://doi.org/10.1182/blood-2025-5601

Published: 2025

Journal Articles

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7354.

https://doi.org/10.1182/blood-2025-7354

Published: 2025

Journal Articles

PRKRA associated with NF-κB activation in pulmonary involvement of idiopathic multicentric castleman disease

Yu-han Gao, Cong-Wei Jia, Zhi-yuan Li, Jia-min Zhou, Zhen-huan Tian, Siyuan Li, Yue Dang, Lu Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 4784.

https://doi.org/10.1182/blood-2025-4784

Published: 2025

Journal Articles

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Ekrem Turk, Fernando Bustamante, Fatima Tuz Zahra, Yu-Han Chen, Rory Shallis, Onyee Chan, Samuel Reynolds, Alison Walker, Ling Zhang, Seongseok Yun, Jeffrey Lancet, David Sallman, Rami Komrokji, Jinming Song, Eric Padron, Gabriela Hobbs, Andrew Kuykendall, Zhuoer Xie

Blood (2025) 146 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2025-3815

Published: 2025

Journal Articles

Germline osmr mutation drives familial unicentric castleman disease with osteosclerosis

Miaoyan Zhang, Yan-ting Liu, Yue Dang, Yu-han Gao, Siyuan Li, Lu Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2025-3536

Published: 2025

Journal Articles

Genotype-specific immune responses at the intestinal barrier predispose to colitis in mouse models of chronic granulomatous disease

Emma Darbinian, Kodjovi D. Mlaga, Prabha Chandrasekaran, Yu Han, Ágnes Donkó, Aléhandra Desjardins, Thomas L. Leto, Steven M. Holland, Johanne Poudrier, Emilia Liana Falcone

Blood (2025) 145 (26): 3153–3165.

https://doi.org/10.1182/blood.2024026332

Published: 2025

Includes: Supplemental data

Journal Articles

Effect of SGLT2 Inhibitors on Erythrocytosis and Arterial Thrombosis Risk in Patients with Type 2 Diabetes Mellitus: A Real-World Multi-Center Cohort Study across the United States

Yu-Han Chen, Tina Yi Jin Hsieh, Andrea Yue-En Sun, Natasha Rastogi, James Cheng-Chung Wei, Cho-Hao Lee

Blood (2024) 144 (Supplement 1): 5214.

https://doi.org/10.1182/blood-2024-207610

Published: 2024

Journal Articles

Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis

Yu-Han Chen, Andrea Yue-En Sun, Karishma Narain, Natasha Rastogi, Cho-Hao Lee

Blood (2024) 144 (Supplement 1): 3553.

https://doi.org/10.1182/blood-2024-198520

Published: 2024

Journal Articles

Clinical Results of a Multicenter Study of the First-in-Human Dual BCMA and CD19 Targeted Novel Platform Fast CAR-T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138614

Published: 2020

Journal Articles

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

Hua Zhang, Lei Gao, Li Liu, Jishi Wang, PhD, Sanbin Wang, Li Gao, Cheng Zhang, MD PhD, Yao Liu, Peiyan Kong, Jia Liu, Jiaping He, Yu Han, Hua Shi, Yan He, Xun Ye, Yi Zhao, Wei Cao, Lianjun Shen, Xi Zhang

Blood (2019) 134 (Supplement_1): 3147.

https://doi.org/10.1182/blood-2019-131056

Published: 2019

Journal Articles

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, PhD, Sanbin Wang, Ligen Liu, Lei Gao, Li Gao, Yao Liu, Peiyan Kong, Jia Liu, Yu Han, Yongliang Zhang, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 1340.

https://doi.org/10.1182/blood-2019-128006

Published: 2019

Journal Articles

A Prospective Analysis of Erythrocyte Membrane Fatty Acid Concentrations and Risk of Non-Hodgkin Lymphoma

Brenda M. Birmann, BA, DSc, MSc, Yu-Han Chiu, MD MPH, Kimberly A. Bertrand, DSc, Shumin Zhang, MD DSc, Francine Laden, DSc, Mara M. Epstein, DSc, Bernard A. Rosner, PhD, Edward L. Giovannucci, MD DSc, Jorge E. Chavarro, DSc, MD MSc

Blood (2016) 128 (22): 1789.

https://doi.org/10.1182/blood.V128.22.1789.1789

Published: 2016

Journal Articles

Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome

Yu Han, Huaquan Wang, MD, Zonghong Shao, MD

Blood (2016) 128 (22): 5522.

https://doi.org/10.1182/blood.V128.22.5522.5522

Published: 2016

Journal Articles

GDF11 Increased in Patients with Myelodysplastic Syndrome

Yu Han, Huaquan Wang, MD, Zonghong Shao, MD

Blood (2015) 126 (23): 5224.

https://doi.org/10.1182/blood.V126.23.5224.5224

Published: 2015

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Prognostic significance of pulmonary involvement in idiopathic multicentric castleman disease

Is 'severe’ imcd-IPL really severe?

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

PRKRA associated with NF-κB activation in pulmonary involvement of idiopathic multicentric castleman disease

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Germline osmr mutation drives familial unicentric castleman disease with osteosclerosis

Genotype-specific immune responses at the intestinal barrier predispose to colitis in mouse models of chronic granulomatous disease

Effect of SGLT2 Inhibitors on Erythrocytosis and Arterial Thrombosis Risk in Patients with Type 2 Diabetes Mellitus: A Real-World Multi-Center Cohort Study across the United States

Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis

Clinical Results of a Multicenter Study of the First-in-Human Dual BCMA and CD19 Targeted Novel Platform Fast CAR-T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

A Prospective Analysis of Erythrocyte Membrane Fatty Acid Concentrations and Risk of Non-Hodgkin Lymphoma

Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome

GDF11 Increased in Patients with Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only